These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands. Rijnders MI, Wolffs PF, Hopstaken RM, den Heyer M, Bruggeman CA, Stobberingh EE. J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345 [Abstract] [Full Text] [Related]
5. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use. Mitra A, Mohanraj M, Shah M. Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847 [Abstract] [Full Text] [Related]
16. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges. Vogel A, Lennon D, Best E, Leversha A. N Z Med J; 2016 Oct 14; 129(1443):77-83. PubMed ID: 27736855 [Abstract] [Full Text] [Related]
18. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Niebuhr M, Mai U, Kapp A, Werfel T. Exp Dermatol; 2008 Nov 14; 17(11):953-7. PubMed ID: 18557929 [Abstract] [Full Text] [Related]
19. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B. Br J Dermatol; 2006 Oct 14; 155(4):680-7. PubMed ID: 16965415 [Abstract] [Full Text] [Related]